Phospholipid-Based Sensors for Industrial, Food, Water, Pharmaceutical, and Soil Quality Monitoring

Publication ID: 24-11857646_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Phospholipid-Based Sensors for Industrial, Food, Water, Pharmaceutical, and Soil Quality Monitoring,” Published Technical Disclosure No. 24-11857646_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857646_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,646.

Summary of the Inventive Concept

The inventive concept leverages the core technology of the original patent to develop novel phospholipid-based sensors for detecting divalent metal cations in various industries, enabling real-time monitoring and quality control.

Background and Problem Solved

The original patent disclosed improved methods for preparing phospholipid-based ultrasound contrast agents. However, the technology's potential extends beyond medical imaging applications. The inventive concept addresses the need for efficient, real-time monitoring of divalent metal cations in industrial processes, food quality, water purity, pharmaceutical formulations, and soil fertility.

Detailed Description of the Inventive Concept

The phospholipid-based sensors utilize the same principles of divalent metal cation susceptibility as the original patent. By adapting the phospholipid blend and formulation to specific industrial, food, water, pharmaceutical, and soil quality monitoring applications, the sensors can detect calcium and/or magnesium levels, providing real-time alerts to operators, quality control personnel, or farmers. The sensors can be integrated into existing monitoring systems or used as standalone devices.

Novelty and Inventive Step

The new claims introduce an entirely new field of application for the core technology, leveraging the unexpected finding of divalent metal cation susceptibility to develop novel sensors for quality monitoring in various industries. This inventive step expands the technology's scope beyond medical imaging, demonstrating a new, non-obvious use for the phospholipid-based formulations.

Alternative Embodiments and Variations

Alternative embodiments may include modifying the phospholipid blend to enhance sensitivity or selectivity for specific divalent metal cations, incorporating additional detection mechanisms, or developing miniaturized or portable sensor devices. Variations may also include adapting the sensors for use in other industries, such as environmental monitoring or cosmetics.

Potential Commercial Applications and Market

The phospholipid-based sensors have significant commercial potential in various industries, including industrial process control, food safety, water treatment, pharmaceutical quality control, and agricultural soil monitoring. The market for these sensors is substantial, with potential customers including industrial manufacturers, food producers, water treatment facilities, pharmaceutical companies, and farmers.

CPC Classifications

SectionClassGroup
A A61 A61K49/223
A A61 A61B8/481
A A61 A61K49/226
A A61 A61K49/227
C C07 C07F9/09
C C07 C07F9/106

Original Patent Information

Patent NumberUS 11,857,646
TitleMethods for making ultrasound contrast agents
Assignee(s)Lantheus Medical Imaging, Inc.